CDH1 (E-cadherin) in testicular germ cell neoplasia: Suppressed translation of mRNA in pre-invasive carcinoma in situ but increased protein levels in advanced tumours

APMIS

Volumn 114, Issue 7-8, 2006, Pages 549-558

  Sonne, Si B ^a   Hoei Hansen, Christina E ^a   Nielsen, John E ^a   Herlihy, Amy S ^a   Andersson, Anna Maria ^a   Almstrup, Kristian ^a,b   Daugaard, Gedske ^a   Skakkebaek, Niels E ^a   Leffers, Henrik ^a   Rajpert De Meyts, Ewa ^a  

^a Rigshospitalet   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Carcinoma in situ; CDH1; E cadherin; Testicular germ cell cancer; Testis

Indexed keywords

GLYCOPROTEIN; MESSENGER RNA; UVOMORULIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CARCINOMA IN SITU; CELL ADHESION; CONTROLLED STUDY; DNA MICROARRAY; EMBRYONAL CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; SEROLOGY; WESTERN BLOTTING;

ADULT; ANIMALS; CADHERINS; CARCINOMA IN SITU; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PRECANCEROUS CONDITIONS; RABBITS; RNA, MESSENGER; TESTICULAR NEOPLASMS;

EID: 33747383487     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_445.x     Document Type: Article

References (29)

1. Okamura D, Kimura T, Nakano T, Matsui Y. Cadherin-mediated cell interaction regulates germ cell determination in mice. Development 2003;130:6423-30.
2. Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR et al. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol 2004;204:167-74.
3. Andersson AM, Edvardsen K, Skakkebaek NE. Expression and localization of N- and E-cadherin in the human testis and epididymis. Int J Androl 1994;17:174-80.
4. Foty RA, Steinberg MS. The differential adhesion hypothesis: a direct evaluation. Dev Biol 2005;278:255-63.
5. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004;303:1483-7.
6. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V et al. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002;21:1948-56.
7. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994;69:580-5.
8. Darai E, Bringuier AF, Walker-Combrouze F, Feldmann G, Madelenat P, Scoazec JY. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Hum Reprod 1998;13:2831-5.
9. Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM et al. The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res 2003;9:6447-52.
10. Kuefer R, Hofer MD, Zorn CS, Engel O, Volkmer BG, Juarez-Brito MA et al. Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer 2005;92:2018-23.
11. Sundfeldt K, Ivarsson K, Rask K, Haeger M, Hedin L, Brannstrom M. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res 2001;21:65-70.
12. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004;48:365-75.
13. D'Souza-Schorey C. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol 2005;15:19-26.
14. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W et al. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 2004;64:4736-43.
15. Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U, Ansorge W, Skakkebaek NE et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer 2005;92:1934-41.
16. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998;83:1002-11.
17. Saito T, Katagiri A, Watanabe R, Tanikawa T, Kawasaki T, Tomita Y et al. Expression of E-cadherin and catenins on testis tumor. Urol Int 2000;65:140-3.
18. Batistatou A, Scopa CD, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ et al. Involvement of dysadherin and E-cadherin in the development of testicular tumours. Br J Cancer 2005;93:1382-7.
19. Giwercman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS 1991;99:586-94.
20. Jorgensen N, Carlsen E, Nermoen I, Punab M, Suominen J, Andersen AG et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod 2002;17:2199-208.
21. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
22. Nielsen JE, Hansen MA, Jorgensen M, Tanaka M, Almstrup K, Skakkebaek NE et al. Germ cell differentiation-dependent and stage-specific expression of LANCL1 in rodent testis. Eur J Histochem 2003;47:215-22.
23. Rajpert-De-Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999;84:3836-44.
24. Kiyosawa H, Mise N, Iwase S, Hayashizaki Y, Abe K. Disclosing hidden transcripts: mouse natural sense-antisense transcripts tend to be poly(A) negative and nuclear localized. Genome Res 2005;15:463-74.
25. Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 2003;22:461-6.
26. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004;2:e363.
27. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-8.
28. Chan AO, Chu KM, Lam SK, Wong BC, Kwok KF, Law S et al. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol 2003;21:2288-93.
29. Gofuku J, Shiozaki H, Doki Y, Inoue M, Hirao M, Fukuchi N et al. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cancer 1998;78:1095-101.